Pharmaron Beijing Co., Ltd. Share Price
Equities
300759
CNE100003JW4
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.13 CNY | -0.41% | -0.36% | -23.64% |
05-20 | Pharmaron Beijing Unit to Sell Proteologix Stake to Johnson & Johnson | MT |
04-30 | Pharmaron Beijing's Profit Rises 17% in 2023 | MT |
Sales 2024 * | 12.75B 1.76B 139B | Sales 2025 * | 14.81B 2.05B 161B | Capitalization | 35.96B 4.97B 391B |
---|---|---|---|---|---|
Net income 2024 * | 1.65B 228M 17.92B | Net income 2025 * | 2.11B 292M 22.94B | EV / Sales 2024 * | 3.07 x |
Net Debt 2024 * | 3.16B 437M 34.34B | Net Debt 2025 * | 2.74B 379M 29.8B | EV / Sales 2025 * | 2.61 x |
P/E ratio 2024 * |
23.9
x | P/E ratio 2025 * |
18.7
x | Employees | - |
Yield 2024 * |
0.97% | Yield 2025 * |
1.3% | Free-Float | 47.74% |
1 day | -0.41% | ||
1 week | -0.36% | ||
Current month | +12.05% | ||
1 month | +21.73% | ||
3 months | +1.75% | ||
6 months | -35.54% | ||
Current year | -23.64% |
Managers | Title | Age | Since |
---|---|---|---|
Xiao Qiang Lou
FOU | Founder | 55 | 30/06/04 |
Bei Zheng
FOU | Founder | 57 | 30/06/04 |
Bo Liang Lou
CEO | Chief Executive Officer | 60 | 30/06/04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kwan Hung Tsang
BRD | Director/Board Member | 60 | 14/08/19 |
Jia Qing Li
BRD | Director/Board Member | 51 | 26/10/16 |
Bo Liang Lou
CEO | Chief Executive Officer | 60 | 30/06/04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.17% | 2 M€ | -14.82% | - |
Date | Price | Change | Volume |
---|---|---|---|
20/05/24 | 22.13 | -0.41% | 19,431,290 |
17/05/24 | 22.22 | +0.05% | 20,646,600 |
16/05/24 | 22.21 | -0.13% | 25,333,610 |
15/05/24 | 22.24 | -0.98% | 30,730,940 |
14/05/24 | 22.46 | +1.13% | 36,477,220 |
End-of-day quote Shenzhen S.E., May 19, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.64% | 4.97B | |
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+46.90% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- 300759 Stock